Cargando…

CDKN2B is critical for verapamil-mediated reversal of doxorubicin resistance in hepatocellular carcinoma

In this study, we explored the function and mechanism of CDKN2B genes in verapamil (VER)-induced reversal of resistance to doxorubicin (ADM) chemotherapy in hepatocellular carcinoma (HCC). We examined 4 HCC cell lines and found that the expression levels of CDKN2B genes correlated with the level of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Tengyue, Ma, Kelong, Huang, Jin, Wang, Shitang, Liu, Yabei, Fan, Gaofei, Liu, Miao, Yang, Guangshan, Wang, Cheng, Fan, Pingsheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5746364/ https://www.ncbi.nlm.nih.gov/pubmed/29299129 http://dx.doi.org/10.18632/oncotarget.22123

Ejemplares similares

Upregulation of Ubiquitin Carboxyl-Terminal Hydrolase L1 (UCHL1) Mediates the Reversal Effect of Verapamil on Chemo-Resistance to Adriamycin of Hepatocellular Carcinoma
por: Yang, Guangshan, et al.
Publicado: (2018)

Clinical evaluation of targeted arterial perfusion of verapamil and chemotherapeutic drugs in interventional therapy of advanced lung cancer
por: Huang, Jin, et al.
Publicado: (2013)

Downregulation of MACC1 facilitates the reversal effect of verapamil on the chemoresistance to active metabolite of irinotecan in human colon cancer cells
por: Qian, Xiaotao, et al.
Publicado: (2022)

Famotidine promotes inflammation by triggering cell pyroptosis in gastric cancer cells
por: Huang, Jin, et al.
Publicado: (2021)

Clinical Evaluation of Targeted Arterial Infusion of Verapamil in the Interventional Chemotherapy of Primary Hepatocellular Carcinoma
por: Huang, Jin, et al.
Publicado: (2010)

Phase I and pharmacokinetic study of D-verapamil and doxorubicin.
por: Bissett, D., et al.
Publicado: (1991)

Pharmacokinetics of doxorubicin co-administered with high-dose verapamil.
por: Gigante, M., et al.
Publicado: (1995)

Loss of miR-638 in vitro promotes cell invasion and a mesenchymal-like transition by influencing SOX2 expression in colorectal carcinoma cells
por: Ma, Kelong, et al.
Publicado: (2014)

Influence of verapamil on the pharmacokinetics of oridonin in rats
por: Liu, Jing, et al.
Publicado: (2019)

Deciphering the pharmacological mechanisms of Fraxini Cortex for ulcerative colitis treatment based on network pharmacology and in vivo studies
por: Wang, Tianming, et al.
Publicado: (2023)

A Critical Role of CDKN3 in Bcr-Abl-Mediated Tumorigenesis
por: Chen, Qinghuang, et al.
Publicado: (2014)

Verapamil potentiation of doxorubicin resistance development in B16 melanoma cells both in vitro and in vivo.
por: Formelli, F., et al.
Publicado: (1988)

Verapamil and Rifampin Effect on P-Glycoprotein Expression in Hepatocellular Carcinoma
por: Jalali, Amir, et al.
Publicado: (2014)

Verapamil in Diabetes
por: Poudel, Resham Raj, et al.
Publicado: (2017)

GRP78-targeted ferritin nanocaged ultra-high dose of doxorubicin for hepatocellular carcinoma therapy
por: Jiang, Bing, et al.
Publicado: (2019)

Effect of verapamil on the pharmacokinetics of hydroxycamptothecin and its potential mechanism
por: Xing, Hua, et al.
Publicado: (2020)

Pharmacokinetic Interaction between Metformin and Verapamil in Rats: Inhibition of the OCT2-Mediated Renal Excretion of Metformin by Verapamil
por: Han, Seung Yon, et al.
Publicado: (2020)

CDKN3 expression is negatively associated with pathological tumor stage and CDKN3 inhibition promotes cell survival in hepatocellular carcinoma
por: Dai, Wei, et al.
Publicado: (2016)

Amiodarone is more efficient than verapamil in reversing resistance to anthracyclines in tumour cells.
por: Chauffert, B., et al.
Publicado: (1987)

Endoplasmic Reticulum Stress–Induced Resistance to Doxorubicin Is Reversed by Paeonol Treatment in Human Hepatocellular Carcinoma Cells
por: Fan, Lulu, et al.
Publicado: (2013)

A Role of Miz-1 in Gfi-1-Mediated Transcriptional Repression of CDKN1A
por: Liu, Qingquan, et al.
Publicado: (2010)

Resveratrol-Mediated Reversal of Doxorubicin-Induced Osteoclast Differentiation
por: Poudel, Sunil, et al.
Publicado: (2022)

CDKN3 expression predicates poor prognosis and regulates adriamycin sensitivity in hepatocellular carcinoma in vitro
por: Dai, Wei, et al.
Publicado: (2020)

REC8 suppresses tumor angiogenesis by inhibition of NF-κB-mediated vascular endothelial growth factor expression in gastric cancer cells
por: Liu, Miao, et al.
Publicado: (2020)

Bacterial magnetosomes loaded with doxorubicin and transferrin improve targeted therapy of hepatocellular carcinoma
por: Wang, Jiaojiao, et al.
Publicado: (2019)

Upregulation of cyclin-dependent kinase inhibitors CDKN1B and CDKN1C in hepatocellular carcinoma-derived cells via goniothalamin-mediated protein stabilization and epigenetic modifications
por: Peng, Yu-Ting, et al.
Publicado: (2015)

CDKN2AIP is critical for spermiogenesis and germ cell development
por: Cao, Yuming, et al.
Publicado: (2022)

CDKN2A is a prognostic biomarker and correlated with immune infiltrates in hepatocellular carcinoma
por: Luo, Jun-peng, et al.
Publicado: (2021)

Influence of verapamil on the pharmacokinetics of rotundic acid in rats and its potential mechanism
por: Shang, Haihua, et al.
Publicado: (2021)

MiR-122 Reverses the Doxorubicin-Resistance in Hepatocellular Carcinoma Cells through Regulating the Tumor Metabolism
por: Pan, Chenwei, et al.
Publicado: (2016)

Anti-Arrhythmic Effect of Verapamil Is Accompanied by Preservation of Cx43 Protein in Rat Heart
por: Zhou, Peng, et al.
Publicado: (2013)

Genetic variants related to successful migraine prophylaxis with verapamil
por: Cutrer, Fred Michael, et al.
Publicado: (2021)

Reversal of doxorubicin-resistance by Salvia miltiorrhiza ligustrazine in the SHG44/doxorubicin glioma drug-resistant cell line
por: Wang, Feng, et al.
Publicado: (2017)

Trandolapril/verapamil combination in hypertensive diabetic patients
por: García Donaire, José A, et al.
Publicado: (2007)

Verapamil: what is the mechanism of its anticarcinogenic activity?
por: Brambilla, G.
Publicado: (1994)

Verapamil Inhibits Aspergillus Biofilm, but Antagonizes Voriconazole
por: Nazik, Hasan, et al.
Publicado: (2017)

Verapamil Targets Membrane Energetics in Mycobacterium tuberculosis
por: Chen, Chao, et al.
Publicado: (2018)

Verapamil as an Adjuvant Treatment for Drug-Resistant Epilepsy
por: Lakshmikanthcharan, S., et al.
Publicado: (2018)

Effects of Verapamil and Diltiazem on the Pharmacokinetics and Pharmacodynamics of Rivaroxaban
por: Kim, Minsoo, et al.
Publicado: (2019)

Verapamil and vasospastic angina: underuse in the elderly population
por: Humbert, Xavier, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_p3u2qv9dvho0e1k6rng2tu6gc0